New Delhi: Doctors from all over the world are constantly engaged in research to prevent the spread of the global epidemic coronavirus. Dozens of research work is going on in various countries to prepare drugs for this epidemic and to prepare vaccines. India is also continuing to work in this direction. In this series, Delhi AIIMS is going to start a human trial of Corona's Vaccine Covaxin from today. The approval was approved on Saturday by the Ethics Committee of the AIIMS for the human trial of covaxin. After which its trial will start from today.
According to the information, within 10 hours of getting permission from the Ethics Committee, 1000 people had registered themselves for this human trial. Only people living in Delhi and NCR have been allowed for this human trial. 12 centers have been set up regarding the vaccine, where its testing has already started, as they had already received approval for this test.
On giving information, Dr. Sanjay Rai, Professor at the Center for Community Medicine at AIIMS, said that the hospital will start registering healthy people from Monday. Today, we have got the indigenous Covaxin vaccine from AIIMS to get the Human Clinical Trial permission from the Ethics Committee. We are starting the registration process from Monday. We will identify healthy people who have no corona history. People aged 18 to 55 will be registered in this research.
Also Read-
40 thousand new corona cases found in a day, more than 27 thousand died
